Search for
Karyotyping For Ambiguous Genetalia
Genetic
Report in 720Hrs
At Home
No Fasting Required
Details
Chromosomal analysis.
₹2,220₹3,171
30% OFF
Karyotyping For Ambiguous Genitalia - Comprehensive Medical Guide
- Why is it done?
- Test measures the complete set of chromosomes to determine genetic sex and identify chromosomal abnormalities in individuals presenting with ambiguous or atypical external genitalia
- Performed to clarify biologic sex in newborns and infants with unclear or inconsistent external genital anatomy at birth
- Identifies sex chromosome abnormalities such as 45,X (Turner syndrome), 47,XXY (Klinefelter syndrome), 47,XYY, or mosaic patterns contributing to genital ambiguity
- Detects autosomal chromosomal abnormalities that may present with ambiguous genitalia and other developmental abnormalities
- Typically performed urgently within first days of life to guide initial sex assignment and medical management decisions
- Essential for differentiating disorders of sex development (DSD), including 46,XY DSD, 46,XX DSD, and sex chromosome DSD
- Helps determine appropriate management strategies and discuss prognosis with parents and healthcare team
- Normal Range
- Normal Genetic Results:
- 46,XX - Female genetic sex with 22 pairs of autosomes plus two X chromosomes (normal female karyotype)
- 46,XY - Male genetic sex with 22 pairs of autosomes plus one X and one Y chromosome (normal male karyotype)
- Abnormal Genetic Results (Significant for Ambiguous Genitalia):
- 45,X - Turner syndrome (complete monosomy or mosaic forms)
- 45,X/46,XX - Mosaic Turner syndrome
- 47,XXY - Klinefelter syndrome
- 47,XYY - XYY syndrome
- 47,XXX - Triple X syndrome
- 46,XX/46,XY - True hermaphroditism or chimerism
- Structural rearrangements - Deletions, translocations, or inversions involving sex chromosomes or autosomes
- Units of Measurement:
- Results reported as karyotype notation describing the complete chromosome complement (total of 46 chromosomes expected)
- No numerical values - results are categorical describing chromosome structure and composition
- Interpretation
- 46,XX Karyotype with Ambiguous Genitalia:
- Indicates genetic female but external genitalia are virilized or ambiguous, suggesting exposure to excess androgens in utero. Most commonly associated with congenital adrenal hyperplasia (CAH), particularly 21-hydroxylase deficiency.
- May also indicate androgen insensitivity from other sources or maternal androgen exposure during pregnancy.
- 46,XY Karyotype with Ambiguous Genitalia:
- Indicates genetic male but external genitalia are undervirilized or ambiguous, suggesting defects in testicular development, androgen production, or androgen receptor function. Requires investigation for specific 46,XY DSD causes.
- May indicate gonadal dysgenesis, testicular synthesis defects, or androgen insensitivity syndrome (AIS).
- Sex Chromosome Abnormalities:
- 45,X (Turner syndrome) - May present with streak gonads and ambiguous or underdeveloped external genitalia, short stature, and associated cardiovascular/renal anomalies.
- 47,XXY (Klinefelter syndrome) - Genetic male with small testes; less commonly presents with ambiguous genitalia but may have underdeveloped secondary sexual characteristics.
- Mosaic patterns (e.g., 45,X/46,XY) - Present with variable phenotype depending on proportion of each cell line; may have asymmetric genital development.
- Structural Chromosome Abnormalities:
- Deletions or translocations involving Y chromosome may result in loss of sex-determining region (SRY) or other critical male-determining genes, leading to undervirilization.
- X-autosome translocations may disrupt genes critical for sexual development.
- Factors Affecting Interpretation:
- Timing of presentation - Ambiguity noted at birth versus discovered later in childhood/adolescence may indicate different etiologies.
- Associated physical findings - Growth retardation, cardiac anomalies, or renal abnormalities may suggest specific syndromes.
- Gonadal histology findings help correlate karyotype with gonadal structure and function.
- Hormonal levels (testosterone, DHT, LH, FSH) provide functional correlation to chromosomal findings.
- Family history may reveal hereditary patterns or consanguinity suggesting autosomal recessive conditions.
- Clinical Significance:
- Results guide appropriate sex assignment and long-term management strategy.
- Identifies need for additional genetic testing (molecular analysis, microarray) if specific gene mutations are suspected.
- Determines surgical and hormonal management options.
- Essential for genetic counseling and family planning discussions.
- Associated Organs
- Primary Organ Systems Involved:
- Reproductive system - Gonads (testes/ovaries), genital tract, and external genitalia are primary structures affected.
- Endocrine system - Chromosomal abnormalities affect hormone production and regulation essential for sexual development.
- Medical Conditions Associated with Abnormal Results:
- Congenital Adrenal Hyperplasia (CAH) - 46,XX karyotype with androgen excess causing virilization of female external genitalia.
- Androgen Insensitivity Syndrome (AIS) - 46,XY karyotype with varying degrees of genital ambiguity due to androgen receptor defects.
- Gonadal Dysgenesis - 45,X or other chromosomal patterns resulting in streak gonads and underdeveloped reproductive structures.
- Turner Syndrome (45,X) - Short stature, webbed neck, cardiac defects (bicuspid aortic valve, coarctation of aorta), renal abnormalities, underdeveloped ovaries.
- Klinefelter Syndrome (47,XXY) - Small firm testes, infertility, tall stature, gynecomastia, variable presentation.
- True Hermaphroditism - 46,XX/46,XY chimerism with both ovarian and testicular tissue.
- Testicular Feminization Syndrome - Complete androgen insensitivity in 46,XY individuals presenting with female phenotype.
- Potential Complications and Risks Associated with Abnormal Results:
- Infertility - Many chromosomal abnormalities result in reduced or absent gamete production.
- Gonadal tumors - Dysgenetic gonads in 46,XY individuals have increased risk of malignant transformation (dysgerminoma, gonadoblastoma).
- Cardiovascular complications - Turner syndrome associated with aortic stenosis, hypertension, and increased cardiovascular mortality.
- Renal abnormalities - Turner syndrome and other DSD conditions may present with kidney dysplasia or structural anomalies.
- Psychological and social impact - Sex assignment decisions based on karyotype must consider long-term psychosocial implications.
- Hormone deficiency - Gonadal insufficiency may require lifelong hormone replacement therapy.
- Recurrent urinary tract infections - Anatomic abnormalities may predispose to infection and kidney damage.
- Follow-up Tests
- Recommended Follow-up Tests Based on Karyotype Results:
- Hormonal Testing - Testosterone, DHT, LH, FSH, ACTH, 17-hydroxyprogesterone to assess endocrine function and identify specific disorders.
- Pelvic and Renal Ultrasound - Evaluates internal reproductive structures (uterus, ovaries, testes), adrenal size, and identifies renal anomalies.
- Molecular Genetic Testing - Targeted gene sequencing for specific DSD genes (SRY, DHH, MAP3K1, DHCR7, etc.) when karyotype is ambiguous or specific condition is suspected.
- Fluorescence In Situ Hybridization (FISH) - Can detect specific chromosomal regions when standard karyotyping shows ambiguity or mosaicism.
- Array Comparative Genomic Hybridization (CGH) - Detects submicroscopic deletions and duplications not visible on standard karyotyping.
- Gonadal Biopsy or Imaging - MRI may provide detailed visualization of gonadal tissue to assess dysgenesis or determine if streak gonads are present.
- Further Investigations When Indicated:
- 46,XX + virilization: hCG stimulation test, adrenal imaging, and 21-hydroxylase gene testing for CAH confirmation.
- 46,XY + undervirilization: testosterone stimulation test, hCG challenge test, imaging for internal reproductive structures.
- Turner syndrome (45,X): Cardiac evaluation (echocardiography, ECG), renal imaging, thyroid function testing, hearing assessment.
- Mosaic patterns: Repeat karyotyping from different tissue sources (skin fibroblasts) to determine tissue distribution of chromosomal abnormality.
- Monitoring Frequency:
- Newborn period - Urgent testing within first days of life when ambiguous genitalia identified.
- Early childhood - Regular assessment every 6-12 months to monitor growth, development, and need for medical/surgical intervention.
- Pubertal development - Close monitoring during puberty to assess development trajectory and need for hormone therapy adjustments.
- Adulthood - Continued follow-up for comorbidity screening (cardiovascular disease, gonadal tumors, bone health) appropriate to specific diagnosis.
- Related Complementary Tests:
- Parental karyotyping - May be indicated if chromosomal rearrangements or mosaicism detected to assess hereditary risk.
- Prenatal diagnosis for future pregnancies - CVS or amniocentesis may be offered to parents with known genetic abnormality.
- Fasting Required?
- Fasting Status:
- No fasting required - Karyotyping does not require fasting. Test can be performed at any time of day.
- Sample Collection Specifications:
- Peripheral blood sample in sterile tube - Typically 2-5 mL of blood collected in EDTA (ethylenediaminetetraacetic acid) anticoagulant tube (lavender top).
- Alternative sample types - Bone marrow, skin fibroblasts, amniotic fluid (for prenatal diagnosis), or chorionic villus samples may be used when indicated.
- Sample stability - Blood sample should be processed within 24-48 hours of collection; viable lymphocytes required for cell culture.
- Special Instructions and Patient Preparation:
- No special preparation needed - No dietary, medication, or activity restrictions required before test.
- Timing consideration - Best performed within first week of life when ambiguous genitalia identified in newborn; earlier results facilitate rapid medical decision-making.
- No medications to avoid - No specific medications need to be held before karyotyping.
- Avoid excessive stress - May be relevant for obtaining adequate sample; calm infant positioning facilitates venipuncture.
- Specimen labeling - Proper patient identification essential; mislabeling can compromise test accuracy.
- Room temperature transport - Blood sample should be kept at room temperature during transport to laboratory; extreme temperatures may reduce cell viability.
- Testing Timeline:
- Standard turnaround time - Results typically available within 7-14 days; high-priority urgent cases may be expedited to 2-3 days.
- FISH testing - When performed for rapid confirmation, results available within 24-48 hours.
How our test process works!

